newsfilter
← Latest News
GlobeNewswire·

Adaptive Biotechnologies to Participate in Upcoming Investor Conferences

SEATTLE, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical